← Eichor
Study identifier: NCT05497349 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Use of Leukocyte-Rich PRP or Leukocyte-Free PRP in the Treatment of Hip Osteoarthritis

Condition: Hip Osteoarthritis  ·  Sponsor: Istituto Ortopedico Rizzoli

PhaseNA
Planned participants230
Who can joinAll sexes, 35 Years to 70 Years
Healthy volunteersNo

About this study

The aim of the study is to compare the efficacy up to 12 months of two different types of PRP (PRP with leukocytes vs PRP depleted of leukocytes) in the echo-guided infiltrative treatment of hip OA by including 230 patients in the study and evaluating them through subjective (using the WOMAC score as the primary outcome) and objective clinical scores.

This description comes directly from the study's public registry record.

Talk to the study team

Dante Dallari, MD  ·  6366318  ·  dante.dallari@ior.it

Roberta Licciardi, MSc  ·  6366567  ·  roberta.licciardi@ior.it

Always discuss trial participation with your own doctor first.

Locations (1)

Istituto Ortopedico RizzoliBologna, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05497349